526445
INDRANIB
Start SIP
Invest Now
Start SIP in INDRANIB
Performance
- Low
- ₹9
- High
- ₹10
- 52 Week Low
- ₹9
- 52 Week High
- ₹35
- Open Price₹10
- Previous Close₹9
- Volume26,022
- 50 DMA₹12.51
- 100 DMA₹13.45
- 200 DMA₹16.86
Investment Returns
- Over 1 Month -28.42%
- Over 3 Month -37.09%
- Over 6 Month -31.22%
- Over 1 Year -71.73%
Smart Investing Starts Here Start SIP with Indrayani Biotech for Steady Growth!
Indrayani Biotech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -5.8
- PEG Ratio
- 0
- Market Cap Cr
- 44
- P/B Ratio
- 0.6
- Average True Range
- 0.84
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.88
- RSI
- 22.62
- MFI
- 23.41
Indrayani Biotech Financials
Indrayani Biotech Technicals
EMA & SMA
Current Price
₹9.67
+
0.25
(2.65%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹11.28
- 50 Day
- ₹12.51
- 100 Day
- ₹13.45
- 200 Day
- ₹16.86
Resistance and Support
9.45
- R3 10.35
- R2 10.01
- R1 9.79
- S1 9.23
- S2 8.89
- S3 8.67
Indrayani Biotech Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-12-11 | Quarterly Results | |
| 2025-08-30 | Others | Inter-alia, to consider 1. Notice of the 33rd AGM of the Company. 2. Appointment of Mr. Swaminathan & Mr. Singarababu Indirakumar as Whole-Time Director. 3. Other business matters. |
| 2025-08-14 | Quarterly Results | |
| 2025-06-12 | Audited Results | (Revised) |
| 2025-04-03 | Rights issue of Equity Shares |
Indrayani Biotech F&O
About Indrayani Biotech
- NSE Symbol
- INDRANIB
- BSE Symbol
- 526445
- Managing Director
- Mr. Kasiraman Sayee Sundar
- ISIN
- INE007C01021
Similar Stocks to Indrayani Biotech
Indrayani Biotech FAQs
Indrayani Biotech share price is ₹9 As on 18 January, 2026 | 04:53
The Market Cap of Indrayani Biotech is ₹44 Cr As on 18 January, 2026 | 04:53
The P/E ratio of Indrayani Biotech is -5.8 As on 18 January, 2026 | 04:53
The PB ratio of Indrayani Biotech is 0.6 As on 18 January, 2026 | 04:53
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.